To include your compound in the COVID-19 Resource Center, submit it here.

Aerie planning $125M note deal

Aerie Pharmaceuticals Inc. (NASDAQ:AERI) proposed Tuesday to raise $125 million

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE